Heart Disease Clinical Trials in Boston

Showing 61-80 of 452 trials

Imaging Histone Deacetylase in the Heart

NCT03549559

The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with diabetes, and healthy volunteers.

Heart Failure With Normal Ejection FractionLeft Ventricular HypertrophyAortic Valve Stenosis+1 more

Massachusetts General Hospital96 participantsStarted Sep 2018

Boston, Massachusetts, United States

RECRUITINGNA< 1 mile

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

NCT06052072

This early feasibility study is intended to characterize the impact of pulmonary artery denervation on the quality of life in Heart Failure Patients with Group 2 Pulmonary Hypertension

Group 2 Pulmonary HypertensionHeart Failure

Gradient Denervation Technologies50 participantsStarted Feb 2024

Chicago, Illinois, United States • Boston, Massachusetts, United States • Durham, North Carolina, United States +5 more locations

RECRUITING< 1 mile

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

NCT00271180

The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.

ArrhythmiaBradycardiaHeart Failure+1 more

Medtronic20,000 participantsStarted Jan 1983

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Chandler, Arizona, United States +315 more locations

Imaging Histone Deacetylase in the Heart

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Heart Disease Trials in Other Cities

A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

A Extension Study of Udenafil in Adolescents

MIcrovascular dysfuNction In Moderate-severe Psoriasis

A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure

Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study

EVOC - EVs in Obesity and Cardiometabolic Disease

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Vitamin D and Omega-3 Trial (VITAL)

Prevention of Serious Adverse Events Following Angiography

SyncAV Post-Market Trial

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)

Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Other Conditions in Boston